首页> 美国卫生研究院文献>Journal of Thoracic Disease >Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report
【2h】

Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report

机译:恶性胸膜间皮瘤患者在Viscum album和Helleborus niger提取物的辅助下较小的消退和长期生存(56个月)—病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Malignant pleural mesothelioma (MPM) is a rare cancer with a dismal prognosis. Viscum album extracts (VAE) have strong immune stimulatory properties, cytotoxic effects, can downregulate cancer genes and inhibit angiogenesis. VAE are often used as an adjunct treatment in cancer patients but have rarely been investigated in MPM. Helleborus niger extracts (HNE) have been used in anticancer therapy since antiquity, and also show tumor specific cytotoxic effects. We present a case of a 64-year old woman with epithelioid MPM of the right chest with node involvement (T2N1M0, stage III). Deciding against the recommended radio-chemotherapy, surgery and pleurodesis, she opted for an integrative treatment approach and was treated with VAE and HNE. After 6 weeks’ treatment, the pleural and nodal MPM manifestations were reduced by about 15%. Subsequent tumor growth was slow, and the patient remained in good health, enabling her to remain physically active until shortly before her death 56 months after the initial diagnosis. This is a rare case of an MPM patient not receiving any standard anticancer treatment; it still shows an extraordinary long survival and good performance status. We presume that VAE and HNE might had an impact on this clinically relevant outcome and therefore should be further investigated in MPM.
机译:恶性胸膜间皮瘤(MPM)是一种罕见的预后不良的癌症。粘胶相册提取物(VAE)具有强大的免疫刺激特性,细胞毒性作用,可以下调癌症基因并抑制血管生成。 VAE通常在癌症患者中用作辅助治疗,但很少在MPM中进行研究。自古以来,黑黎芦提取物(HNE)已用于抗癌治疗,并且还显示出肿瘤特异性的细胞毒性作用。我们提出了一例64岁女性,右胸上皮样MPM伴有淋巴结受累(T2N1M0,III期)。考虑到推荐的放疗,手术和胸膜固定术,她选择了综合治疗方法,并接受了VAE和HNE治疗。治疗6周后,胸膜和淋巴结的MPM表现降低了约15%。随后的肿瘤生长缓慢,并且患者保持了良好的健康状况,使她能够保持身体活动,直到初诊后56个月死亡。这是MPM患者未接受任何标准抗癌治疗的罕见情况。它仍然显示出超长的使用寿命和良好的性能状态。我们认为VAE和HNE可能对该临床相关结果产生影响,因此应在MPM中进行进一步研究。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号